Moriel Vandsburger1, Katrien Vandoorne1, Roni Oren1, Avigdor Leftin1, Senzeni Mpofu1, Daniela Delli Castelli1, Silvio Aime1, Michal Neeman2. 1. From the Departments of Biological Regulation (M.V., K.V., R.O., S.M., M.N.) and Chemical Physics (A.L.), Weizmann Institute of Science, Rehovot, Israel; Department of Physiology and Biomedical Engineering, University of Kentucky, Lexington (M.V.); and Molecular Biotechnology Center, University of Torino, Torino, Italy (D.D.C., S.A.). 2. From the Departments of Biological Regulation (M.V., K.V., R.O., S.M., M.N.) and Chemical Physics (A.L.), Weizmann Institute of Science, Rehovot, Israel; Department of Physiology and Biomedical Engineering, University of Kentucky, Lexington (M.V.); and Molecular Biotechnology Center, University of Torino, Torino, Italy (D.D.C., S.A.). Michal.neeman@weizmann.ac.il.
Abstract
BACKGROUND: Application of emerging molecular MRI techniques, including chemical exchange saturation transfer (CEST)-MRI, to cardiac imaging is desirable; however, conventional methods are poorly suited for cardiac imaging, particularly in small animals with rapid heart rates. We developed a CEST-encoded steady state and retrospectively gated cardiac cine imaging sequence in which the presence of fibrosis or paraCEST contrast agents was directly encoded into the steady-state myocardial signal intensity (cardioCEST). METHODS AND RESULTS: Development of cardioCEST: A CEST-encoded cardiac cine MRI sequence was implemented on a 9.4T small animal scanner. CardioCEST of fibrosis was serially performed by acquisition of a series of CEST-encoded cine images at multiple offset frequencies in mice (n=7) after surgically induced myocardial infarction. Scar formation was quantified using a spectral modeling approach and confirmed with histological staining. Separately, circulatory redistribution kinetics of the paramagnetic CEST agent Eu-HPDO3A were probed in mice using cardioCEST imaging, revealing rapid myocardial redistribution, and washout within 30 minutes (n=6). Manipulation of vascular tone resulted in heightened peak CEST contrast in the heart, but did not alter redistribution kinetics (n=6). At 28 days after myocardial infarction (n=3), CEST contrast kinetics in infarct zone tissue were altered, demonstrating gradual accumulation of Eu-HPDO3A in the increased extracellular space. CONCLUSIONS: cardioCEST MRI enables in vivo imaging of myocardial fibrosis using endogenous contrast mechanisms, and of exogenously delivered paraCEST agents, and can enable multiplexed imaging of multiple molecular targets at high-resolution coupled with conventional cardiac MRI scans.
BACKGROUND: Application of emerging molecular MRI techniques, including chemical exchange saturation transfer (CEST)-MRI, to cardiac imaging is desirable; however, conventional methods are poorly suited for cardiac imaging, particularly in small animals with rapid heart rates. We developed a CEST-encoded steady state and retrospectively gated cardiac cine imaging sequence in which the presence of fibrosis or paraCEST contrast agents was directly encoded into the steady-state myocardial signal intensity (cardioCEST). METHODS AND RESULTS: Development of cardioCEST: A CEST-encoded cardiac cine MRI sequence was implemented on a 9.4T small animal scanner. CardioCEST of fibrosis was serially performed by acquisition of a series of CEST-encoded cine images at multiple offset frequencies in mice (n=7) after surgically induced myocardial infarction. Scar formation was quantified using a spectral modeling approach and confirmed with histological staining. Separately, circulatory redistribution kinetics of the paramagnetic CEST agent Eu-HPDO3A were probed in mice using cardioCEST imaging, revealing rapid myocardial redistribution, and washout within 30 minutes (n=6). Manipulation of vascular tone resulted in heightened peak CEST contrast in the heart, but did not alter redistribution kinetics (n=6). At 28 days after myocardial infarction (n=3), CEST contrast kinetics in infarct zone tissue were altered, demonstrating gradual accumulation of Eu-HPDO3A in the increased extracellular space. CONCLUSIONS: cardioCEST MRI enables in vivo imaging of myocardial fibrosis using endogenous contrast mechanisms, and of exogenously delivered paraCEST agents, and can enable multiplexed imaging of multiple molecular targets at high-resolution coupled with conventional cardiac MRI scans.
Authors: Jiadi Xu; Kannie W Y Chan; Xiang Xu; Nirbhay Yadav; Guanshu Liu; Peter C M van Zijl Journal: Magn Reson Med Date: 2016-02-22 Impact factor: 4.668
Authors: Ashley Pumphrey; Zhengshi Yang; Shaojing Ye; David K Powell; Scott Thalman; David S Watt; Ahmed Abdel-Latif; Jason Unrine; Katherine Thompson; Brandon Fornwalt; Giuseppe Ferrauto; Moriel Vandsburger Journal: NMR Biomed Date: 2016-01 Impact factor: 4.044
Authors: Ashley L Pumphrey; Shaojing Ye; Zhengshi Yang; Jennifer Simkin; John C Gensel; Ahmed Abdel-Latif; Moriel H Vandsburger Journal: Radiology Date: 2016-07-15 Impact factor: 11.105
Authors: Anne H Schmieder; Shelton D Caruthers; Jochen Keupp; Samuel A Wickline; Gregory M Lanza Journal: Engineering (Beijing) Date: 2016-03-16 Impact factor: 7.553